NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 55 min ago
Notice of Question and Answer "Office Hours" with NIH Staff for Intervention Research to Improve Native American Health (IRINAH): PAR-23-298, PAR-23-285, PAR-23-299
Notice NOT-DA-24-015 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of the Expiration Date for PAR-21-167 "Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Notice NOT-OD-24-070 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Research Training in Aging for Medical Students (T35)
Funding Opportunity RFA-AG-25-009 from the NIH Guide for Grants and Contracts. The primary goal of this Institutional Research Training Grant is to provide short-term training for medical students to obtain necessary aging research experiences and technical expertise and skills early during their education to encourage them to pursue careers in research. Other health professional students may also benefit from such short-term training and are eligible when research training is a minor part of, or nonexistent in, their doctoral program. This Notice of Funding Opportunity Announcement (NOFO) does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
Categories: Job Watch, Literature Watch
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
Funding Opportunity RFA-AA-24-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the planning phase of the Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities. MCCI is a multi-ICO dissemination and implementation science initiative to advance health equity and end health disparities in racial/ethnic minority women and girls of reproductive age. Specifically, the Model Continuums of Care Initiative will apply the latest dissemination and implementationscience approaches to significantly reduce the prevalence and impact of multi-morbidity among racial/ethnic minority women and girls of reproductive age at risk and living with mental health disorders, substance use disorders, chronic stress, cardiopulmonary diseases, common metabolic disorders (e.g., diabetes), cancer, and HIV/AIDS. This concept proposes a continuum of care approach that integrates preventive health services, primary care, behavioral health, integrative care, and cardiopulmonary and endocrine specialties to fully address health care needs in each of these domains, and to have maximum impact on the overall health and well-being ofracial and ethnic minority and other underserved women and girls. While MCCI is not a maternal health initiative, women and girls ages 15-44 yrs. are centered because it is during the early reproductive period, i.e., adolescence, that multimorbidity typically begins and rapidly progresses, setting the stage for multiple chronic debilitating conditions in later life. Special emphasis will be placed on using stakeholder partnerships, provider training, and infrastructure changes to improve access for subgroups of racial/ethnic minority women and girls who currently have the least access to high quality health care (e.g., racial/ethnic minority women and girls living in low resource settings).
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Training and Career Development in Dissemination and Implementation Science for Research in Communication Disorders
Notice NOT-DC-24-024 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Participation of NIMH in PAR-23-302, "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)"
Notice NOT-MH-24-200 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Participation of the National Institute of Nursing Research (NINR) in NOT-OD-24-038, "Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable"
Notice NOT-NR-24-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 Clinical Trial Optional)
Funding Opportunity RFA-NR-24-005 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support research to improve health and promote health equity in rural populations. Rural populations experience high rates of many causes of morbidity and disability, and high and increasing rates of premature death. Meaningful and sustained improvements in the health of rural populations require effective solutions to address the underlying causes. Applications responding to this Notice of Funding Opportunity (NOFO) should develop, adapt, or implement intervention strategies addressing social determinants of health (SDOH) to improve health and promote health equity in rural populations. This funding opportunity encourages studies that use a wide range of methodological approaches that enhance access to, and acceptability and effectiveness of, interventions in rural populations, such as community-engaged research approaches that build on the strengths of rural communities.
Categories: Job Watch, Literature Watch
Notice of Correction to Key Dates Listed in PAR-24-091 and PAR-24-092 - Multidisciplinary Studies of HIV/AIDS and Aging (R01 and R21 Clinical Trial Optional)
Notice NOT-AG-24-008 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification of NIMH Specific Areas of Research Interest in PAR-22-181 Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
Notice NOT-MH-24-375 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): U.S. Health in the International Perspective
Notice NOT-AG-24-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Funding Opportunity PA-24-141 from the NIH Guide for Grants and Contracts. The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
Categories: Job Watch, Literature Watch
Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment Clinical Trials Clinical Centers (U01-Clinical Trial required)
Funding Opportunity RFA-AA-24-004 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Notice of Funding Opportunity (NOFO) is to leverage the established clinical infrastructure of the previously funded program on Late Phase Clinical Trials and Observational Studies in Alcoholic Hepatitis. The existing program of AH Clinical and Translational Network, hereafter termed AlcHepNet, has been sponsored by the NIAAA since 2012 and was renewed in 2018. In the next cycle the program will consist of up to six Clinical Study Sites and one Data Coordinating Center to conduct an integrated treatment clinical trial that incorporates active treatment of Alcohol Use Disorder (AUD) with treatment of alcohol-associated liver disease (ALD). The targeted patient population will include severe alcohol-associated hepatitis (sAH) and decompensated alcohol-associated cirrhosis (deAC). Through this Request for Applications (RFA), U01 Collaborative Cooperative Agreement applications are sought to conduct an investigator-initiated common protocol integrated ALD-AUD treatment clinical trial and site-specific ancillary studies. Each Clinical Center application must consist of a multidisciplinary investigative team that includes a hepatologist and an addiction medicine specialist, and be comprised of primary and if necessary, subsites with a track record of successful enrollment in past clinical trials.
Categories: Job Watch, Literature Watch
Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-185, "Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed)"
Notice NOT-DC-24-022 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed)
Notice NOT-NS-24-053 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice Announcing the NIH Common Fund Data Ecosystem (CFDE) Cloud Workspace Implementation Center (OT2)
Notice NOT-RM-24-005 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AT-24-008 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) will support development, adaptation, and/or applications of computational tools to aggregate and analyze orthogonal chemical and/or biological data sets related to natural products with the aim of generating novel testable hypotheses regarding their biological activity and role in the context of whole person health research. Projects must leverage and merge multiple compatible or interoperable sources and/or types of data. Use of artificial intelligence and machine learning approaches is encouraged. This NOFO is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).
Categories: Job Watch, Literature Watch
Notice of Change to Application Types Allowed in PAR-23-267 "Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)"
Notice NOT-TR-24-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Application Types Allowed in PAR-23-268 Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Notice NOT-TR-24-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-186, "Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed)"
Notice NOT-DC-24-023 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch